Thermal Water Applications in the Treatment of Upper Respiratory Tract Diseases: A Systematic Review and Meta-Analysis

Table 5

Results of nasal resistance.

	Patients	NasRes	CI 95%	𝑃 value
Thermal (sulphur +radon)
Baseline	212	0,442260114	[0.26; 0.62]
2 weeks	137	0.257467503	[0.22; 0.30]	0.051
30 days	66	0.113901251	[0.05; 0.18]	<0.01^∗
90 days	64	0.159927083	[0.003; 0.32]	<0.05^∗
ISCS
Baseline	115	0.516633	[0.13; 0.90]
2 weeks	40	1.28	[1.16; 1.40]	<0.01
30 days	62	0.124408602	[0.10; 0.15]	<0.05
90 days	68	0.617283393	[−0.36; 1.60]	0.851
Placebo
Baseline	20	0.23	[0.19; 0.27]
2 weeks	20	0.19	[0.17; 0.21]	<0.05^∗
Radon
Baseline	60	0.364606147	[0.33; 0.40]
2 weeks	60	0.240700629	[0.15; 0.33]	<0.05^∗
Sulphur
Baseline	152	0.495021367	[0.22; 0.77]
2 weeks	77	0.272182942	[0.26; 0.29]	0.118
30 days	66	0.113901251	[0.05; 0.18]	<0.01^∗
90 days	64	0.159927083	[0.003; 0.32]	<0.05^∗

∗Significant in comparison to baseline (𝑃<0.05).